Influenza virus: A master tactician in innate immune evasion and novel therapeutic interventions

Frontiers in Immunology

Volumn 9, Issue APR, 2018, Pages

  Hsu, Alan Chen Yu ^a,b  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Hemagglutinin; Influenza; Influenza A virus; NS1; Polymerase acidic 1 F2; Therapeutics; Virulence factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTRUCTURAL PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RNA POLYMERASE; SIALIDASE; VIRUS NUCLEOPROTEIN; VOLTAGE DEPENDENT ANION CHANNEL 1;

IMMUNE EVASION; INFLUENZA VIRUS; INNATE IMMUNITY; NONHUMAN; PANDEMIC INFLUENZA; REVIEW; RNA BINDING; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS TRANSMISSION;

EID: 85045383824     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00743     Document Type: Review

References (114)

1. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 206(2):148-57. doi:10.1093/infdis/jis337
2. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med (2011) 365(26):2541-2. doi:10.1056/NEJMc1111078
3. Lamb RA, Choppin PW. The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 52:467-506. doi:10.1146/annurev.bi.52.070183.002343
4. Palese P, Shaw ML, editors. Orthomyxoviridae: The Viruses and Their Replication. Philadelphia: Lippincott Williams & Wilkins (2007)
5. Zebedee SL, Lamb RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 62(8):2762-72
6. Baudin F, Bach C, Cusack S, Ruigrok RW. Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J (1994) 13(13):3158-65
7. Compans RW, Content J, Duesberg PH. Structure of the ribonucleoprotein of influenza virus. J Virol (1972) 10(4):795-800
8. Murti KG, Webster RG, Jones IM. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology (1988) 164(2):562-6. doi:10.1016/0042-6822(88)90574-0
9. Carr CM, Kim PS. Flu virus invasion: halfway there. Science (1994) 266(5183):234-6. doi:10.1126/science.7939658
10. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 12:627-61. doi:10.1146/annurev.cellbio.12.1.627
11. Whittaker GR, Helenius A. Nuclear import and export of viruses and virus genomes. Virology (1998) 246(1):1-23. doi:10.1006/viro.1998.9165
12. Zhirnov OP. Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology (1992) 186(1):324-30. doi:10.1016/0042-6822(92)90090-C
13. Bui M, Whittaker G, Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol (1996) 70(12):8391-401
14. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol (1991) 65(1):232-44
15. Scheiffele P, Roth MG, Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J (1997) 16(18):5501-8. doi:10.1093/emboj/16.18.5501
16. Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 74(10):4634-44. doi:10.1128/JVI.74.10.4634-4644.2000
17. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology (1997) 227(2):493-9. doi:10.1006/viro.1996.8323
18. Ito T, Suzuki Y, Suzuki T, Takada A, Horimoto T, Wells K, et al. Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2, 3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol (2000) 74(19):9300-5. doi:10.1128/JVI.74.19.9300-9305.2000
19. Ryan-Poirier K, Suzuki Y, Bean WJ, Kobasa D, Takada A, Ito T, et al. Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res (1998) 56(2):169-76. doi:10.1016/S0168-1702(98)00067-7
20. Rogers GN, Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology (1983) 127(2):361-73. doi:10.1016/0042-6822(83)90150-2
21. Baum LG, Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem (1990) 40:35-8
22. Suzuki Y, Matsunaga M, Matsumoto M. N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J Biol Chem (1985) 260(3):1362-5
23. Ito T, Suzuki Y, Takada A, Kawamoto A, Otsuki K, Masuda H, et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 71(4):3357-62
24. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 72(9):7367-73
25. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 360(25):2616-25. doi:10.1056/NEJMoa0903812
26. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med (2009) 361(2):115-9. doi:10.1056/NEJMp0904572
27. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 205(1):17-23. doi:10.1006/viro.1994.1615
28. Rogers GN, D'Souza BL. Receptor binding properties of human and animal H1 influenza virus isolates. Virology (1989) 173(1):317-22. doi:10.1016/0042-6822(89)90249-3
29. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 486(7403):420-8. doi:10.1038/nature10831
30. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 336(6088):1534-41. doi:10.1126/science.1213362
31. Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res (2014) 42(Web Server issue):W252-8. doi:10.1093/nar/gku340
32. Russier M, Yang G, Rehg JE, Wong SS, Mostafa HH, Fabrizio TP, et al. Molecular requirements for a pandemic influenza virus: an acid-stable hemagglutinin protein. Proc Natl Acad Sci U S A (2016) 113(6):1636-41. doi:10.1073/pnas.1524384113
33. Cummings RD, Soderquist AM, Carpenter G. The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells. Presence of complex-type N-linked chains that contain terminal N-acetylgalactosamine residues. J Biol Chem (1985) 260(22):11944-52
34. Yen HY, Liu YC, Chen NY, Tsai CF, Wang YT, Chen YJ, et al. Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition. Proc Natl Acad Sci U S A (2015) 112(22):6955-60. doi:10.1073/pnas.1507329112
35. Hsu AC, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, et al. Targeting PI3K-p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 191(9):1012-23. doi:10.1164/rccm.201501-0188OC
36. Kedzierski L, Tate MD, Hsu AC, Kolesnik TB, Linossi EM, Dagley L, et al. Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling. Elife (2017) 6:e20444. doi:10.7554/eLife.20444
37. EierhoffT, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog (2010) 6(9):e1001099. doi:10.1371/journal.ppat.1001099
38. Glaser L, Conenello G, Paulson J, Palese P. Effective replication of human influenza viruses in mice lacking a major alpha2, 6 sialyltransferase. Virus Res (2007) 126(1-2):9-18. doi:10.1016/j.virusres.2007.01.011
39. Hsu AC, Barr I, Hansbro PM, Wark PA. Human influenza is more effective than avian influenza at antiviral suppression in airway cells. Am J Respir Cell Mol Biol (2011) 44(6):906-13. doi:10.1165/rcmb.2010-0157OC
40. Nunes-Correia I, Eulalio A, Nir S, Pedroso de Lima MC. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol Biol Lett (2004) 9(1):47-60
41. Rapoport EM, Mochalova LV, Gabius HJ, Romanova J, Bovin NV. Search for additional influenza virus to cell interactions. Glycoconj J (2006) 23(1-2):115-25. doi:10.1007/s10719-006-5444-x
42. Clements ML, Subbarao EK, Fries LF, Karron RA, London WT, Murphy BR. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol (1992) 30(3):655-62
43. Subbarao EK, London W, Murphy BR. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol (1993) 67(4):1761-4
44. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, et al. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2010) 84(3):1597-606. doi:10.1128/JVI.01783-09
45. Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol (2005) 79(18):12058-64. doi:10.1128/JVI.79.18.12058-12064.2005
46. Gabriel G, Dauber B, WolffT, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A (2005) 102(51):18590-5. doi:10.1073/pnas.0507415102
47. Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y. Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 83(10):5278-81. doi:10.1128/JVI.00063-09
48. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 18(15):20453
49. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 368(20):1888-97. doi:10.1056/NEJMoa1304459
50. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 63(11):4603-8
51. Snyder MH, Buckler-White AJ, London WT, Tierney EL, Murphy BR. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol (1987) 61(9):2857-63
52. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 7(12):1306-12. doi:10.1038/nm1201-1306
53. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 1(1):e4. doi:10.1371/journal.ppat.0010004
54. Yoshizumi T, Ichinohe T, Sasaki O, Otera H, Kawabata S, Mihara K, et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat Commun (2014) 5:4713. doi:10.1038/ncomms5713
55. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 446(7138):916-20. doi:10.1038/nature05732
56. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 122(5):669-82. doi:10.1016/j.cell.2005.08.012
57. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol (2003) 4(5):491-6. doi:10.1038/ni921
58. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem (1998) 67:227-64. doi:10.1146/annurev.biochem.67.1.227
59. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature (2001) 413(6857):732-8. doi:10.1038/35099560
60. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest (2009) 136(3):678-87. doi:10.1378/chest.08-2420
61. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol (2003) 21:335-76. doi:10.1146/annurev.immunol.21.120601.141126
62. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol (2012) 86(16):8359-66. doi:10.1128/JVI.01122-12
63. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 7(6):e1002067. doi:10.1371/journal.ppat.1002067
64. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 2(4):240-9. doi:10.1016/j.chom.2007.09.001
65. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog (2007) 3(10):1414-21. doi:10.1371/journal.ppat.0030141
66. McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog (2013) 9(5):e1003392. doi:10.1371/journal.ppat.1003392
67. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 80(16):7976-83. doi:10.1128/JVI.00415-06
68. Pinar A, Dowling JK, Bitto NJ, Robertson AA, Latz E, Stewart CR, et al. PB1-F2 peptide derived from avian influenza A virus H7N9 induces inflammation via activation of the NLRP3 inflammasome. J Biol Chem (2017) 292(3):826-36. doi:10.1074/jbc. M116.756379
69. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol (2004) 78(12):6304-12. doi:10.1128/JVI.78.12.6304-6312.2004
70. Bruns K, Studtrucker N, Sharma A, Fossen T, Mitzner D, Eissmann A, et al. Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem (2007) 282(1):353-63. doi:10.1074/jbc. M606494200
71. Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci (1957) 147(927):268-73. doi:10.1098/rspb.1957.0049
72. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 147(927):258-67. doi:10.1098/rspb.1957.0048
73. Hatada E, Fukuda R. Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol (1992) 73(Pt 12):3325-9. doi:10.1099/0022-1317-73-12-3325
74. Privalsky ML, Penhoet EE. The structure and synthesis of influenza virus phosphoproteins. J Biol Chem (1981) 256(11):5368-76
75. Chien CY, Xu Y, Xiao R, Aramini JM, Sahasrabudhe PV, Krug RM, et al. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry (2004) 43(7):1950-62. doi:10.1021/bi030176o
76. Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA (1995) 1(9):948-56
77. Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J (1999) 18(8):2273-83. doi:10.1093/emboj/18.8.2273
78. NemeroffME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3' end formation of cellular pre-mRNAs. Mol Cell (1998) 1(7):991-1000. doi:10.1016/S1097-2765(00)80099-4
79. Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology (2003) 307(2):386-95. doi:10.1016/S0042-6822(02)00127-7
80. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, et al. Suppression of the antiviral response by an influenza histone mimic. Nature (2012) 483(7390):428-33. doi:10.1038/nature10892
81. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2007) 81(2):514-24. doi:10.1128/JVI.01265-06
82. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 74(17):7989-96. doi:10.1128/JVI.74.17.7989-7996.2000
83. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5(5):439-49. doi:10.1016/j.chom.2009.04.006
84. Bornholdt ZA, Prasad BV. X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 456(7224):985-8. doi:10.1038/nature07444
85. Wang X, Basler CF, Williams BR, Silverman RH, Palese P, Garcia-Sastre A. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol (2002) 76(24):12951-62. doi:10.1128/JVI.76.24.12951-12962.2002
86. Lu Y, Wambach M, Katze MG, Krug RM. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 214(1):222-8. doi:10.1006/viro.1995.9937
87. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, WolffK, Palese P, et al. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 74(13):6203-6. doi:10.1128/JVI.74.13.6203-6206.2000
88. Dauber B, Schneider J, WolffT. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol (2006) 80(23):11667-77. doi:10.1128/JVI.01142-06
89. Li S, Min JY, Krug RM, Sen GC. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology (2006) 349(1):13-21. doi:10.1016/j.virol.2006.01.005
90. Min JY, Li S, Sen GC, Krug RM. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology (2007) 363(1):236-43. doi:10.1016/j.virol.2007.01.038
91. Min JY, Krug RM. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A (2006) 103(18):7100-5. doi:10.1073/pnas.0602184103
92. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 103(38):14194-9. doi:10.1073/pnas.0606109103
93. Li Y, Anderson DH, Liu Q, Zhou Y. Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity. J Biol Chem (2008) 283(34):23397-409. doi:10.1074/jbc. M802737200
94. Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol (2007) 81(23):12730-9. doi:10.1128/JVI.01427-07
95. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, et al. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol (2007) 88(Pt 5):1403-9. doi:10.1099/vir.0.82764-0
96. Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL. Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol (2007) 81(4):1838-47. doi:10.1128/JVI.01667-06
97. Solorzano A, Webby RJ, Lager KM, Janke BH, Garcia-Sastre A, Richt JA. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol (2005) 79(12):7535-43. doi:10.1128/JVI.79.12.7535-7543.2005
98. Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, et al. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol (2008) 82(1):220-8. doi:10.1128/JVI.00978-07
99. Twu KY, Kuo RL, Marklund J, Krug RM. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol (2007) 81(15):8112-21. doi:10.1128/JVI.00006-07
100. Hsu AC, Parsons K, Barr I, Lowther S, Middleton D, Hansbro PM, et al. Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection. PLoS One (2012) 7(3):e32947. doi:10.1371/journal.pone.0032947
101. Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014-2015 influenza season. Cell Rep (2015) 12(1):1-6. doi:10.1016/j.celrep.2015.06.005
102. Nguyen-Van-Tam JS, Venkatesan S, Muthuri SG, Myles PR. Neuraminidase inhibitors: who, when, where? Clin Microbiol Infect (2015) 21(3):222-5. doi:10.1016/j.cmi.2014.11.020
103. Wolkewitz M, Schumacher M. Neuraminidase inhibitors and hospital mortality in British patients with H1N1 influenza A: a re-analysis of observational data. PLoS One (2016) 11(9):e0160430. doi:10.1371/journal.pone.0160430
104. Chen Q, Guo Y. Influenza viral hemagglutinin peptide inhibits influenza viral entry by shielding the host receptor. ACS Infect Dis (2016) 2(3):187-93. doi:10.1021/acsinfecdis.5b00139
105. Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol (2006) 80(24):11960-7. doi:10.1128/JVI.01678-06
106. Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. A novel family of peptides with potent activity against influenza A viruses. J Gen Virol (2012) 93(Pt 5):980-6. doi:10.1099/vir.0.038679-0
107. Cederlund A, Gudmundsson GH, Agerberth B. Antimicrobial peptides important in innate immunity. FEBS J (2011) 278(20):3942-51. doi:10.1111/j.1742-4658.2011.08302.x
108. Gutsmann T, Razquin-Olazaran I, Kowalski I, Kaconis Y, Howe J, Bartels R, et al. New antiseptic peptides to protect against endotoxin-mediated shock. Antimicrob Agents Chemother (2010) 54(9):3817-24. doi:10.1128/AAC.00534-10
109. Hoffmann J, Schneider C, Heinbockel L, Brandenburg K, Reimer R, Gabriel G. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment. Antiviral Res (2014) 104:23-33. doi:10.1016/j.antiviral.2014.01.015
110. Ghanem A, Mayer D, Chase G, Tegge W, Frank R, Kochs G, et al. Peptide-mediated interference with influenza A virus polymerase. J Virol (2007) 81(14):7801-4. doi:10.1128/JVI.00724-07
111. Li C, Ba Q, Wu A, Zhang H, Deng T, Jiang T. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly. FEBS J (2013) 280(4):1139-49. doi:10.1111/febs.12107
112. Fleishman SJ, Whitehead TA, Ekiert DC, Dreyfus C, Corn JE, Strauch EM, et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science (2011) 332(6031):816-21. doi:10.1126/science.1202617
113. Whitehead TA, Chevalier A, Song Y, Dreyfus C, Fleishman SJ, De Mattos C, et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol (2012) 30(6):543-8. doi:10.1038/nbt.2214
114. Kadam RU, Juraszek J, Brandenburg B, Buyck C, Schepens WBG, Kesteleyn B, et al. Potent peptidic fusion inhibitors of influenza virus. Science (2017) 358(6362):496-502. doi:10.1126/science.aan0516